Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call Transcript
Viking Therapeutics held its Q1 2026 earnings call on April 29, 2026, during which company executives discussed financial results and business developments. The management team, including CEO Brian Lian and CFO Gregory Zante, provided updates on the company's pipeline and commercial strategy. Analysts from various research firms participated in the call, asking questions about the company's progress and outlook.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4896162-viking-therapeutics-inc-vktx-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
